Therapeutic Proteins

About:

Therapeutic Proteins develops and commercializes biosimilar recombinant therapeutic proteins.

Description:

Therapeutic Proteins International, LLC. manufactures and markets bio-similar recombinant therapeutic proteins. Its portfolio of products includes small-dose cytokines, large-dose monoclonal antibodies and fusion proteins, and in situ pegylation of difficult to conjugate molecules. The company was founded in 2003 and is based in Chicago, Illinois.

Total Funding Amount:

$2.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Deerfield, Illinois, United States

Founded Date:

2003-01-01

Founders:

Sarfaraz K. Niazi

Number of Employees:

51-100

Last Funding Date:

2010-07-13

IPO Status:

Private

Industries: